[Carbohydrate metabolism and beta-blocking agents: effects of atenolol therapy].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D001262:Atenolol / Q000009:adverse effects* / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D050260:Carbohydrate Metabolism; D048909:Diabetes Complications; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D007328:Insulin; D011412:Propanolamines; D001262:Atenolol
Metabolismo glicidico e beta-bloccanti: effetti della terapia con atenololo.